Studies on enzyme inhibition remain a crucial area in drug discovery since these studies have led to the discoveries of new lead compounds useful in the treatment of several diseases. In this study, protocatechuic acid (PCA), an active compound from Hibiscus sabdariffa L. has been evaluated for its inhibitory properties against jack bean urease (JBU) as well as its possible toxic effect on human gastric epithelial cells (GES-1). Anti-urease activity was evaluated by an Electrospray Ionization-Mass Spectrometry (ESI-MS) based method, while cytotoxicity was assayed by the MTT method. PCA exerted notable anti-JBU activity compared with that of acetohydroxamic acid (AHA), with IC50 values of 1.7 and 3.2 µM, respectively. PCA did not show any significant cytotoxic effect on (GES-1) cells at concentrations ranging from 1.12 to 3.12 µM. Molecular docking study revealed high spontaneous binding ability of PCA to the active site of urease. Additionally, the anti-urease activity was found to be related to the presence of hydroxyl moieties of PCA. This study presents PCA as a natural urease inhibitor, which could be used safely in the treatment of diseases caused by urease-producing bacteria.

Department of Applied Ecology Faculty of Environmental Sciences Czech University of Life Sciences Prague Kamýcká 129 165 21 Praha 6 Suchdol Czech Republic

Department of Natural Drugs Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Brno Palackého tř 1946 1 612 42 Brno Czech Republic

See more in PubMed

Mazzei L., Cianci M., Musiani F., Ciurli S. Inactivation of urease by 1,4-benzoquinone: Chemistry at the protein surface. Dalton Trans. 2016;45:5455–5459. doi: 10.1039/C6DT00652C. PubMed DOI

Taha M., Ismail N.H., Imran S., Wadood A., Rahim F., Riaz M. Synthesis of potent urease inhibitors based on disulfide scaffold and their molecular docking studies. Bioorg. Med. Chem. 2015;23:7211–7218. doi: 10.1016/j.bmc.2015.10.017. PubMed DOI

Konieczna I., Zarnowiec P., Kwinkowski M., Kolesinska B., Fraczyk J., Kaminski Z., Kaca W. Bacterial urease and its role in long-lasting human diseases. Curr. Protein Pept. 2012;13:789–806. doi: 10.2174/138920312804871094. PubMed DOI PMC

Awllia J.A.J., Sara A., Wahab A.-T., Al-Ghamdi M., Rasheed S., Huwait E., Iqbal Choudhary M. Discovery of new inhibitors of urease enzyme: A study using STD-NMR spectroscopy. Lett. Drug Des. Discov. 2015;12:819–827. doi: 10.2174/1570180812666150520001629. DOI

Kosikowska P., Berlicki Ł. Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review. Expert Opin. Ther. Pat. 2011;21:945–957. doi: 10.1517/13543776.2011.574615. PubMed DOI

Follmer C.J. Ureases as a target for the treatment of gastric and urinary infections. Clin. Pathol. 2010;63:424–430. doi: 10.1136/jcp.2009.072595. PubMed DOI

Mobley H.L., Island M.D., Hausinger R.P. Molecular biology of microbial ureases. Microbiol. Rev. 1995;59:451–480. PubMed PMC

Hassan S.T.S., Žemlička M. Plant-derived urease inhibitors as alternative chemotherapeutic agents. Arch. Pharm. 2016;349:507–522. doi: 10.1002/ardp.201500019. PubMed DOI

Ibrar A., Khan I., Abbas N. Structurally diversified heterocycles and related privileged scaffolds as potential urease inhibitors: A brief overview. Arch. Pharm. 2013;346:423–446. doi: 10.1002/ardp.201300041. PubMed DOI

Tanaka T., Kawase M., Tani S. Urease inhibitory activity of simple α,β-unsaturated ketones. Life Sci. 2003;73:2985–2990. doi: 10.1016/S0024-3205(03)00708-2. PubMed DOI

Islam N.U., Amin R., Shahid M., Amin M., Zaib S., Iqbal J. A multi-target therapeutic potential of Prunus domestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties. BMC Complement. Altern. Med. 2017;17:276. doi: 10.1186/s12906-017-1791-3. PubMed DOI PMC

Modolo L.V., de Souza A.X., Horta L.P., Araujo D.P., de Fátima Â. An overview on the potential of natural products as ureases inhibitors: A review. J. Adv. Res. 2015;6:35–44. doi: 10.1016/j.jare.2014.09.001. PubMed DOI PMC

Saeed A., Mahesar P.A., Channar P.A., Larik F.A., Abbas Q., Hassan M., Raza H., Seo S.Y. Hybrid pharmacophoric approach in the design and synthesis of coumarin linked pyrazolinyl as urease inhibitors, kinetic mechanism and molecular docking. Chem. Biodivers. 2017;14:e1700035. doi: 10.1002/cbdv.201700035. PubMed DOI

Mazzei L., Cianci M., Contaldo U., Musiani F., Ciurli S. Urease inhibition in the presence of N-(n-Butyl) thiophosphoric triamide, a suicide substrate: Structure and kinetics. Biochemistry. 2017;56:5391–5404. doi: 10.1021/acs.biochem.7b00750. PubMed DOI

You Z., Yu H., Zheng B., Zhang C., Lv C., Li K., Pan L. Syntheses, structures, and inhibition studies of Jack bean urease by copper(II) complexes derived from a tridentate hydrazone ligand. Inorg. Chim. Acta. 2017 doi: 10.1016/j.ica.2017.09.011. in press. DOI

Deng H.H., Hong G.L., Lin F.L., Liu A.L., Xia X.H., Chen W. Colorimetric detection of urea, urease, and urease inhibitor based on the peroxidase-like activity of gold nanoparticles. Anal. Chim. Acta. 2016;915:74–80. doi: 10.1016/j.aca.2016.02.008. PubMed DOI

Hassan S.T.S., Šudomová M. The development of urease inhibitors: What opportunities exist for better treatment of helicobacter pylori infection in children? Children. 2017;4:2. doi: 10.3390/children4010002. PubMed DOI PMC

Hassan S.T.S., Berchová K., Šudomová M. Antimicrobial, antiparasitic and anticancer properties of Hibiscus sabdariffa (L.) and its phytochemicals: In vitro and in vivo studies. Ceska Slov. Farm. 2016;65:10–14. PubMed

Da-Costa-Rocha I., Bonnlaender B., Sievers H., Pischel I., Heinrich M. Hibiscus sabdariffa L.—A phytochemical and pharmacological review. Food Chem. 2014;165:424–443. doi: 10.1016/j.foodchem.2014.05.002. PubMed DOI

Hopkins A.L., Lamm M.G., Funk J.L., Ritenbaugh C. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: A comprehensive review of animal and human studies. Fitoterapia. 2013;85:84–94. doi: 10.1016/j.fitote.2013.01.003. PubMed DOI PMC

Hassan S.T.S., Berchová K., Majerová M., Pokorná M., Švajdlenka E. In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. Pharm. Biol. 2016;54:1736–1740. doi: 10.3109/13880209.2015.1126618. PubMed DOI

Hassan S.T.S., Švajdlenka E., Berchová-Bímová K. Hibiscus sabdariffa L. and its bioactive constituents exhibit antiviral activity against HSV-2 and anti-enzymatic properties against urease by an ESI-MS based assay. Molecules. 2017;22:722. doi: 10.3390/molecules22050722. PubMed DOI PMC

Khan A.K., Rashid R., Fatima N., Mahmood S., Mir S., Khan S., Jabeen N., Murtaza G. Pharmacological activities of protocatechuic acid. Acta Pol. Pharm. 2015;72:643–650. PubMed

Semaming Y., Pannengpetch P., Chattipakorn S.C., Chattipakorn N. Pharmacological properties of protocatechuic Acid and its potential roles as complementary medicine. Evid. Based Complement. Altern. Med. 2015;2015:593902. doi: 10.1155/2015/593902. PubMed DOI PMC

Kakkar S., Bais S. A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacol. 2014;2014:952943. doi: 10.1155/2014/952943. PubMed DOI PMC

Tanaka T., Kawase M., Tani S. Alpha-hydroxyketones as inhibitors of urease. Bioorg. Med. Chem. 2004;12:501–505. doi: 10.1016/j.bmc.2003.10.017. PubMed DOI

Scheurer M., Brauch H.J., Schmidt C.K., Sacher F., Zerulla W., Barth T., Dressel J., Erhardt K., Locquenghien K.H., Pasda G. Occurrence and fate of nitrification and urease inhibitors in the aquatic environment. Environ. Sci. Process. Impacts. 2016;34:79–84. PubMed

Krajewska B., Zaborska W., Chudy M. Multi-step analysis of Hg2+ ion inhibition of jack bean urease. J. Inorg. Biochem. 2004;98:1160–1168. doi: 10.1016/j.jinorgbio.2004.03.014. PubMed DOI

Lin H.H., Chen J.H., Chou F.P., Wang C.J. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-κB pathway and MMP-2 production by targeting RhoB activation. Br. J. Pharmacol. 2011;162:237–254. doi: 10.1111/j.1476-5381.2010.01022.x. PubMed DOI PMC

Lin H.H., Chen J.H., Huang C.C., Wang C.J. Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation. Int. J. Cancer. 2007;120:2306–2316. doi: 10.1002/ijc.22571. PubMed DOI

Vitaglione P., Donnarumma G., Napolitano A., Galvano F., Gallo A., Scalfi L., Fogliano V. Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr. 2007;137:2043–2048. PubMed

Chun O.K., Chung S.J., Song W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007;137:1244–1252. PubMed

Kay C.D., Mazza G., Holub B.J., Wang J. Anthocyanin metabolites in human urine and serum. Br. J. Nutr. 2004;91:933–942. doi: 10.1079/BJN20041126. PubMed DOI

Filiz E., Vatansever R., Ozyigit I.I. Molecular docking of Glycine max and Medicago truncatula ureases with urea; bioinformatics approaches. Mol. Biol. Rep. 2016;43:129–140. doi: 10.1007/s11033-016-3945-7. PubMed DOI

Amtul Z., Rahman A.U., Siddiqui R.A., Choudhary M.I. Chemistry and mechanism of urease inhibition. Curr. Med. Chem. 2002;9:1323–1348. doi: 10.2174/0929867023369853. PubMed DOI

Farrugia M.A., Macomber L., Hausinger R.P. Biosynthesis of the urease metallocenter. J. Biol. Chem. 2013;288:3178–3185. doi: 10.1074/jbc.R112.446526. PubMed DOI PMC

Chen Y.C. Beware of docking! Trends Pharmacol. Sci. 2015;36:78–95. doi: 10.1016/j.tips.2014.12.001. PubMed DOI

Shelley J.C., Cholleti A., Frye L.L., Greenwood J.R., Timlin M.R., Uchimaya M. Epik: A software program for pKa prediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 2007;21:681–691. doi: 10.1007/s10822-007-9133-z. PubMed DOI

Xian Y.F., Lin Z.X., Mao Q.Q., Hu Z., Zhao M., Che C.T., Ip S.P. Bioassay-guided isolation of neuroprotective compounds from Uncaria rhynchophylla against β-amyloid-induced neurotoxicity. Evid. Based Complement Altern. Med. 2012;2012:802625. doi: 10.1155/2012/802625. PubMed DOI PMC

Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455–461. doi: 10.1002/jcc.21334. PubMed DOI PMC

Musiani F., Arnofi E., Casadio R., Ciurli S. Structure-based computational study of the catalytic and inhibition mechanisms of urease. J. Biol. Inorg. Chem. 2001;6:300–314. doi: 10.1007/s007750000204. PubMed DOI

Dassault Systèmes BIOVIA . Discovery Studio Modeling Environment. Dessault Systemes; San Diego, CA, USA: 2017. Release 2017.

DeLano W.L. The PyMOL Molecular Graphics System. DeLano Scientific; San Carlos, CA, USA: 2002.

Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights

Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers

Brassicasterol with Dual Anti-Infective Properties against HSV-1 and Mycobacterium tuberculosis, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments

A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases

A Multi-Biochemical and In Silico Study on Anti-Enzymatic Actions of Pyroglutamic Acid against PDE-5, ACE, and Urease Using Various Analytical Techniques: Unexplored Pharmacological Properties and Cytotoxicity Evaluation

Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties

In Vitro Study of Multi-Therapeutic Properties of Thymus bovei Benth. Essential Oil and Its Main Component for Promoting Their Use in Clinical Practice

Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations